Evaluation of Clinical Outcomes of an Isofocal Optic-Design Intraocular Lens with Double C-Loop Haptics in Eyes with Glaucoma.
All eyes achieved 20/20 or better corrected distance vision after this intraocular lens implant in glaucoma eyes
Evaluation of Clinical Outcomes of an Isofocal Optic-Design Intraocular Lens with Double C-Loop Haptics in Eyes with Glaucoma.
To assess the refractive and visual outcomes after implantation of an isofocal optic-design intraocular lens (intraocular lens) with double C-loop haptics following cataract surgery in eyes with primary open-angle glaucoma (primary open-angle glaucoma).
This was a prospective, open-label, interventional exploratory study that considered primary open-angle glaucoma eyes undergoing cataract surgery with implantation of the Isopure Serenity (Beaver-Visitec International, Inc. [BVI], Waltham, MA, USA) intraocular lens.
The mean spherical equivalent and refractive cylinder were -0.06 ± 0.30 D and -0.13 ± 0.33 D, respectively.
Furthermore, 95.45% and 77.27% of eyes presented a monocular distance-corrected intermediate visual acuity value of ≥20/32 at 80 and 66 cm, respectively, and 68.18% of eyes presented a monocular distance-corrected near visual acuity value of ≥20/40.
The mean monocular corrected distance visual acuity, distance-corrected intermediate visual acuity at 80 cm, distance-corrected intermediate visual acuity at 66 cm, and distance-corrected near visual acuity were -0.09 ± 0.04, 0.12 ± 0.07, 0.21 ± 0.07 and 0.32 ± 0.07 logMAR, respectively.
The isofocal Isopure Serenity intraocular lens can be implanted in eyes with primary open-angle glaucoma after cataract surgery, achieving a satisfactory visual performance.
Our results suggest that this intraocular lens model is a viable option for selected patients with controlled early/moderate primary open-angle glaucoma and without central visual field involvement diagnosed with cataracts.